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Background: Recent studies have shown strong evidence that bronchiolitis obliterans is
the major long-term sequelae of exposure to sulfur mustard (SM). This study is the first to
examine the histopathologic spectrum of changes in a large number of surgical lung
biopsies from patients exposed to SM.
Method: Fifteen patients with chronic respiratory disease from mustard gas exposure
were divided into severe (6 cases) and mild exposure (9 cases). All had surgical (open or
thoracoscopic) lung biopsy, pulmonary function tests (PFTs) and chest high-resolution
computed tomography scan (HRCT).
Result: The mean age of the cases was 43.879.6 (range 33–65). All patients had dyspnea
and cough as the two main complaints. Only one patient was a smoker. Thirteen patients
had normal PFTs, while one had obstruction and one had mild restriction. Six (66.6%)
patients in the mild exposure and 3 (50%) in the severe exposure group showed evidence of
more than 25% air trapping on chest HRCT. Among the mild group, 3 had features of
constrictive bronchiolitis and another had features suggestive of this (bronchiolectasis and
mucus stasis). The next most common finding was a mild-to-moderate chronic cellular
bronchiolitis (3 patients). Two among the 6 in the severe group showed constrictive
bronchiolitis and one showed features suggestive of constrictive bronchiolitis.Elsevier Ltd. All rights reserved.
88053770; fax: +98 21 88040106.
m (M. Ghanei).
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M. Ghanei et al.826Conclusion: We conclude that about half of patients had diagnostic constrictive
bronchiolitis, or bronchiolectasis and mucus stasis consistent with more proximal luminal
compromise. The fact that there were no differences between the low- and high-dose
groups suggests that effects of SM are not solely dependent on the severity of exposure.
The results also indicate that the diagnosis of chronic lung disease due to SM may be
difficult. Surgical lung biopsy may be helpful in difficult cases, as constrictive (obliterative)
bronchiolitis can be present in symptomatic patients with normal PFTs and chest HRCT.
& 2008 Elsevier Ltd. All rights reserved.Background and aims
Sulfur mustard (SM), a potent toxic fume, was used
extensively against both military and civilian populations
by Iraqi forces in the 1980–1988 Iran–Iraq war.1 Acutely it
produces severe mucosal injuries of the skin, eyes and
respiratory system, but there is increasing evidence that it is
also responsible for the ongoing respiratory injury that may
not manifest for many years. Emad and Rezaian2 reported
the late clinical findings in 197 exposed patients and found
evidence of chronic bronchitis (58.8%), bronchiectasis
(8.62%) and fibrosis (12.8%). Other reports, however, have
identified constrictive (obliterative) bronchiolitis as the
main late complication of mustard gas exposure,3–7 but no
large comprehensive pathologic study based on surgical
biopsies has yet been reported.
Therefore, we undertook an international collaborative
study to better define the histopathologic features of
chronic respiratory disease from mustard gas exposure and
correlate them with clinical presentation, computed tomo-
graphy appearance and pulmonary function tests (PFTs).
Design
Data were obtained from the medical records available at a
major university hospital that provides tertiary medical care
and maintains a large database of patients exposed to
chemical warfare agents during the Iran–Iraq war. Standar-
dized patient interviews utilizing a previously published
questionnaire8 were also performed.
Inclusion and exclusion criteria
For inclusion in the study, patients had to have some level
of exposure to SM, have had a surgical (open or thoraco-
scopic) lung biopsy and PFTs. Patients were excluded if
they had a history of significant occupational or other
environmental exposures or a connective tissue disease.
Smoking history was quantified by pack-years and did not
constitute a reason for exclusion. Fifteen patients who had
completed the consent form have been included in the
study.
Data collection
All clinical records were reviewed and the following
information were abstracted: age at presentation with
symptoms, gender, time from exposure to presentation,
PFTs including: FEV1, FVC and FEV1/FVC. A diagnosis ofobstructive disease was rendered if FEV1/FVC was o0.7,
and the absolute FEV1 o80% of the predicted. Restrictive
disease was diagnosed when FVC was o80% of predicted,
and the ratio of FEV1/FVC was40.7. The ratio of FEV1/FVC
40.7 and FVC 480% was considered as normal.9 Data was
not available on lung volumes or diffusing capacity.
Patients were divided into those with severe exposure
(defined by their having a documented hospitalization
(frequently with other symptoms of exposure, such as skin
blistering) at the time of initial exposure) and mild exposure
(defined as those who reported having been exposed, but
who were not actually hospitalized and lacked a history of
blistering or other acute phase manifestations).
Chest high-resolution computed tomography scan (HRCT)
was performed on all patients using the following protocol:
collimation: 1–1.5mm, interval scan: 10 and 2mm, scan
time: 1–2 s, matrix: 512 512, field of view as small as
possible including both lungs, window level ¼ 600HU
(range 500 to 900HU), with level I, 500 HU (range I,
100–2000HU).
Surgical procedures were performed under general
anesthesia with concurrent bronchoscopy. If possible,
biopsies were obtained from two different lobes of the lung
at the interface between apparent normal and pathologic
tissue. All specimens were sent fresh to pathology, paraffin
embedded and stained with hematoxylin–eosin, Masson
trichrome and elastic tissue stains according to standard
procedures.Data review
All cases (see below) were initially reviewed in a blinded
fashion without the knowledge of clinical features by 6
pathologists, from Italy (Department of Pathology, Univer-
sity of Verona), USA (Department of Laboratory Medicine
and Pathology, Mayo Clinic Arizona) and Iran (Research
Center of Chemical Injuries, Baqiyatallah Medical Sciences
University and Shahid Beheshti University, Tehran). Standar-
dized scoring sheets were developed with special attention
to bronchiolar pathology from a previously published system
utilized in the assessment of lung pathology in idiopathic
pulmonary fibrosis and nylon-flock workers.8 After scoring all
features individually, each pathologist provided a prelimin-
ary diagnosis for each case. The next session of the work
group was held with the attending pulmonologists, radiol-
ogists and pathologists. All cases were reviewed with full
clinical history, radiologic findings, collected histopathologic
scoring and checklist. A final pathologic diagnosis was then
determined for each patient.
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The study was conducted in accordance with the principles
embodied in the declaration of Helsinki, and the project
design was approved by an appropriate institutional ethics
committee. All patients had signed an informed consent
form before participating in the study.
Results
Between February 2004 and May 2005, 15 patients met our
inclusion criteria and were entered into the study. The
clinical characteristics of the patients are summarized in
Table 1. All patients were exposed to SM approximately 20
years previously and are still alive at the time of this report.
The mean age and standard deviation (mean7SD) of the
cases was 43.879.6 (range 33–65). All patients were
suffering from chronic respiratory disease for approximately
17 years. Dyspnea and cough were the main complaints.
Other common complaints were, in decreasing order of
frequency: sputum production, hemoptysis and chest pain.
Only one patient was a smoker. Thirteen patients had normal
PFTs, while one had obstruction and one had mild restriction
(Table 1).
Chest HRCT findings
Six (66.6%) patients in the mild exposure group and 3 (50%)
of the severe exposure group showed evidence of air
trapping involving 425% of the lung.
Histologic findings
Among the mild group all had some evidence of pathology
centered on the small airways, although one current
cigarette smoker had very mild changes, which could be
attributable to smoking or mustard gas exposure. Interest-
ingly, this patient also had a normal CT scan and minimal
evidence of obstruction. One patient had respiratory
bronchiolitis, implying that he smoked, but he denied this
history, a phenomenon that has been previously reported.10
Three had features of obliterative (constrictive) bronchilitis.
All these cases had partial luminal narrowing by the
presence of plaque-like increases in submucosal collagen
(Figure 1). In some cases this increase in collagen was
circumferential, while in others it was partial. These airway
walls frequently appeared somewhat rigid and lacked the
normal mucosal convolutions (Figure 2). The process was
sometimes accompanied by a mild-to-moderate lymphocytic
infiltrate. In some of the cases, other bronchioles in the
biopsy were dilated and showed mucus stasis indicating
proximal obstruction. The next most common finding was
the presence of a mild-to-moderate chronic cellular
bronchiolitis. One of these patients (65-year-old man) also
had goblet cell metaplasia of terminal bronchioles, mild
bronchiolectasis and mucus stasis, the latter suggesting that
he may have had airway stenosis proximally. The biopsy from
the patient with follicular bronchiolitis as the main finding
also had honeycomb change, but fibroblast foci or other
features to suggest a diagnosis of usual interstitial pneumo-
nia were absent. Two among the 6 severely exposed patientsshowed constrictive bronchiolitis and one showed bronchio-
lectasis (Figure 3), again suggesting that he likely had airway
stenosis not represented on the slides.
Follow-up
All patients have had slowly progressive symptoms, despite
treatment with inhaled bronchodilators and corticosteroids,
macrolides. In the severe group progression was initiated
immediately after presentation and followed without
any symptom-free period, but it was approximately after
7 years in the mild group. None, however, required lung
transplantation.
Discussion
This study represents, to our knowledge, the largest series
of patients with histologically documented bronchiolar
disease due to SM exposure. Among our 14 patients with
sufficient material for analysis, 50% had diagnostic oblit-
erative bronchiolitis or features which strongly suggest that
it was present, i.e. bronchioliectasis and mucus stasis. The
next most common group had varying degrees of bronchiolar
inflammation which could account for their symptoms; and
interestingly 2 patients had disease likely not the result of
exposure, but due to smoking and organic antigens, although
the patient with histologic features of hypersensitivity
pneumonitis had no obvious exposure.
This study is also the first to classify patients according to
the degree of exposure. Our clinical and pathologic data
show that there were no differences between the low- and
high-dose groups. This suggests that effects of SM are not
dependent on exposure severity.
In addition to airway pathology, one patient had
honeycomb lung (7%). This figure is very close to the findings
of Emad and Rezaian2 who identified pulmonary fibrosis in
12% of patients, although their findings were not based on
histologic analysis.
This study highlights several other interesting points
about SM gas-exposed patients, which are relevant to the
diagnosis of new patients. First, air trapping was identified
in 60% of our group, similar to the reports of other
authors.4,6,7 Air trapping is recognized as the main imaging
finding in patients with obliterative bronchiolitis although it
is not specific and may also be seen in patients with various
obstructive and airway diseases, including emphysema,
asthma, Swyer–James syndrome, bronchiectasis, and cystic
fibrosis. Also, 20% of our patients with air trapping seen on
routine expiratory chest HRCT scans had inspiratory scans
considered normal. Although a variety of diseases can show
air trapping on expiratory chest HRCT scans, its presence in
patients with normal findings on inspiratory scans are seen
primarily in cases of bronchiolitis obliterans and asth-
ma.11–16 Interestingly, it was identified in 3/9 (33.3%) of
our patients who did not have constrictive bronchiolitis
histologically. Although air trapping does point to the
presence of significant airway disease, it can be seen in
healthy subjects with normal PFTs.17–20 There was no
specific pattern of chest HRCT for toxic fume-induced
constrictive bronchiolitis in our series. In the post lung
transplant setting, chest HRCT reportedly has 91% sensitivity
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Table 1 Demographic, PFT, Chest HRCT data and pathologic diagnosis of patients.
Low-dose exposure group High-dose exposure group
Age
(years)
40 40 56 33 36 65 33 38 40 38 41 48 47 43 60
Sex m m m m m m m m m m m m m m m
Years
from
exposure
17 21 18 19 23 21 20 20 18 20 20 21 20 20 21
Smoking
(pack-
years)
– – – – – – – 5 – – – – – – –
Signs and
symp-
toms
Cough + + + + + + + + + + + + + + +
Dyspnea + + + + + + + + + + + + + + +
Sputum + – – + + + + + + + + – – – +
Chest
pain
– + + + – + – – – – – + + – -
Hemopty-
sis
+ – + – – – + + + + + – – – +
Spirome-
try
FEV1
(percent)
3.8 (95) 2.9 (81) 3.2 (90) 2.0 (52) 3.3 (86) 2.3 (85) 4.3 (88) 4.4 (104) 3.8 (92) 4.4 (99) 2.9 (76) 3.3 (96) 3.0 (83.2) 3.7 (84.3) 2.8 (82.5)
FVC
(percent)
4.8 (91) 3.7 (88) 4.3 (96) 2.2 (47) 5.9 (88) 3.0 (86) 6.1 (102) 5.0 (102) 5.1 (101) 5.5 (104) 3.7 (75) 4.5 (1 0 1) 4.0 (87.3) 4.7 (90.3) 3.2 (76.6)
FEV1/FVC 77 76 75 94 56 76 71 87 75 80 79 73 75 78 86
Pattern
of
disorder
Nl Nl Nl Obstruction Mild
restriction
Nl Nl Nl Nl Nl Nl Nl Nl Nl Nl
Chest
HRCT
Air
trapping
+ + + + + + N N N + + N N N +
Bronch-
iectasis
N N N N N N N N N N N N + N N
Bronchial
wall
thicken-
ing
+ N + + N N N N + N N + + N +
Pathology
diagnosis
Constrictive
bronchiolitis
Constrictive
bronchiolitis
Constrictive
bronchiolitis
Chronic
cellular
bronchiolitis
Chronic
cellular
bronchiolitis
Chronic
cellular
bronchiolitis
and
bronchiolec-
tasis
Respiratory
bronchiolitis
Mild
chronic
peri-
bronchioli-
tis
Follicular
bronchiolitis
Constrictive
bronchiolitis
Constrictive
bronchiolitis
Chronic
cellular
bronchiolitis
Bronchio-
lectasis
Hypersensi-
tive
pneumonitis
Inadequate
Nl: normal.
N: negative.
+ Air trapping: air trapping involving 425% of the lung.
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Figure 1 Constrictive (obliterative) bronchiolitis in a 40-year-
old patient with mild exposure to SM 17 years previously with
circumferential increase in collagen, highlighted by arrowheads
(inset).
Figure 2 Constrictive (obliterative) bronchiolitis in a 56-year-
old man patient with mild exposure to SM 18 years previously. A,
low power, shows the increase in connective tissue bands cut
longitudinally (arrows) with flattening of the overlying epithe-
lium, while B shows connective tissue bands in cross-section
(arrowheads).
Figure 3 Mild bronchiolectasis (in comparison to the adjacent
artery) with mild mucus stasis in a 41-year-old man with sever
exposure to SM 20 years previously. Other bronchioles showed
constrictive (obliterative) bronchiolitis.
Pathologic study of surgical lung biopsies from mustard gas-exposed patients 829and it is a valuable tool for establishing the diagnosis of
obliterative bronchiolitis.21 But in our patients, it neither
excluded nor confirmed the diagnosis of bronchiolitis.
Perhaps this is because the degree of obliteration present
in our patients was somewhat less than that seen in many
lung transplant recipients.
Second, PFTs have been proven helpful in diagnosing
idiopathic constrictive bronchiolitis and bronchiolitis oblit-
erans syndrome (BOS) at an early stage.22 However, all but
two of our patients had normal PFTs. This is in keeping with
other studies which have shown that patients with oblit-
erative bronchiolitis may have a variety of PFTs patterns,
including normal.23 This emphasizes that the clinical work
up may not always reflect the pathology as expected, and
the type of PFT abnormality does not predict the mode of
presentation, histology or chest HRCT results. Clinicians
should have a high degree of suspicion for the diagnosis of
SM-gas-induced airway disease if patients have an appro-
priate history of exposure and symptoms, despite atypical
PFT findings.
Finally, the clinical presentation in these patients may not
always suggest that airway disease is the main diagnostic
problem for these patients. Although shortness of breath
and chronic cough even with normal or near normal chest
HRCT and PFTs would strongly suggest the presence of
bronchiolitis to most clinicians, some of our patients
presented with sputum production (66%) and hemoptysis
(53%). The results of this study, therefore, suggest that
hemoptysis alone or in combination with air trapping in a
non-smoker may be more common in patients with
bronchiolitis than previously appreciated and in SM-exposed
individuals might be a clue to SM-induced airway disease.
In conclusion, significant airway disease including con-
strictive (obliterative) bronchiolitis may be present in
symptomatic patients exposed to SM even when chest HRCT
and PFTs are normal. Thus, open or thoracoscopic lung
biopsy plays a critical role in the diagnosis of SM-exposed
patients. Clinicians who encounter exposed patients with
unexplained cough, progressive exertional dyspnea, and
ARTICLE IN PRESS
M. Ghanei et al.830fixed airflow limitation, with or without restriction, should
consider constrictive (obliterative) bronchiolitis in the
differential diagnosis.Author contributions
Dr. Ghanei had full access to all of the data in the study, had
the final responsibility for the decision to submit for
publication and takes responsibility for the integrity of the
data and the accuracy of the data analysis.
Study concept and design: Ghanei, Tazelaar, Chilosi.
Study supervision: Ghanei, Tazelaar, Chilpsi, Bahadori.
Acquisition of data: Ghanei, Akbari, Shamsaei.
Analysis and interpretation of data: Amini, Peyman.
Drafting of the manuscript: Ghanei, Tazelaar, Chilosi,
Amini, Peyman, Akbari, Mohammadi.
Critical revision of the manuscript for important in-
tellectual content: Ghanei, Tazelaar, Amini, Aslani, Akbari,
Peyman, Aslani.
Administrative, technical, or material support: Ghanei,
Tazelaar, Chilosi, Akbari, Shamsaei, Bahadori, Mohammadi,
Aslani.Conflict of interest statement
All authors of this work disclose that they had no conflicts of
interest.References
1. Security Council of the United Nations. Report of specialists
appointed by the Secretary General to investigate allegations
by the Islamic Republic of Iran concerning the use of chemical
weapons. New York Security Council of United Nations, 1986,
Document S/16433/1986.
2. Emad A, Rezaian GR. The diversity of the effects of sulfur
mustard gas inhalation on respiratory system 10 years after a
single, heavy exposure: analysis of 197 cases. Chest 1997;112:
734–48.
3. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F,
Karkhane A. Fibrogenic cytokine levels in bronchoalveolar
lavage aspirates 15 years after exposure to sulfur mustard.
Am J Physiol Lung Cell Mol Physiol 2004;287:1160–4.
4. Ghanei M, Mokhtari M, Mohammad MM, Aslani J, Nematizadeh F.
Long-term respiratory disorders of claimers with subclinical
exposure to chemical warfare agents. Inhal Toxicol 2004;16:
491–5.
5. Thomason JW, Rice TW, Milstone AP. Bronchiolitis obliterans
in a survivor of a chemical weapons attack. JAMA 2003;290:
598–9.6. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis
obliterans following exposure to sulfur mustard: chest high
resolution computed tomography. Eur J Radiol 2004;52:164–9.
7. Ghanei M, Moqadam FA, Mohammad MM, Aslani J. Tracheo-
bronchomalacia and air trapping following mustard gas ex-
posure. Am J Respir Crit Care Med 2006;173:304–9.
8. Boag AH, Colby TV, Fraire AE, Kuhn III C, Roggli VL, Travis WD,
et al. The pathology of interstitial lung disease in nylon flock
workers. Am J Surg Pathol 1999;23:1539–45.
9. Series ATS/ERS Task Force: Standardisation of Lung Function
Testing. Interpretative strategies for lung function tests. Eur
Respir J 2005;26:948–68.
10. Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory
bronchiolitis: a clinicopathologic study in current smokers, ex-
smokers, and never-smokers. Am J Surg Pathol 2002;26:647–53.
11. Knudson RJ, Standen JR, Kaltenborn WT, Knudson DE, Rehm K,
Habib MP, et al. Expiratory computed tomography for assess-
ment of suspected pulmonary emphysema. Chest 1991;99:
1357–66.
12. Stern EJ, Samples TL. Dynamic ultrafast high resolution CT
findings in a case of Swyer–James syndrome. Pediatr Radiol
1992;22:350–2.
13. Moore AD, Godwin JD, Dietrich PA, Verschakelen JA, Henderson
Jr WR. Swyer–James syndrome: findings in eight patients. Am J
Roentgenol 1992;158:1211–5.
14. Aquino SL, Webb WR, Golden J. Bronchiolitis obliterans
associated with rheumatoid arthritis: findings on HRCT and
dynamic expiratory CT. J Comput Assist Tomogr 1994;18:555–8.
15. Hansell DM, Wells AU, Rubens MB, Cole PJ. Bronchiectasis:
functional significance decreased attenuation at expiratory.
Radiology 1994;193:369–74.
16. Stern EJ, Webb WR, Warnock ML, Salmon CJ. Bronchopulmonary
sequestration: dynamic, ultrafast, high-resolution CT evidence
of air trapping. Am J Roentgenol 1991;157:947–9.
17. Chen D, Webb WR, Storto ML, Lee KN. Assessment of air
trapping using postexpiratory high-resolution computed tomo-
graphy. J Thorac Imag 1998;13:135–43.
18. Webb WR, Stern EJ, Kanth N, Gamsu G. Dynamic pulmonary CT:
findings in healthy adult men. Radiology 1993;186:117–24.
19. Lee KW, Chung SY, Yang I, Lee Y, Ko EY, Park MJ. Correlation of
aging and smoking with air trapping at thin-section CT of the
lung in asymptomatic subjects. Radiology 2000;214:831–6.
20. Tanaka N, Matsumoto T, Miura G, Emoto T, Matsunaga N, Ueda K,
et al. Air trapping at CT: high prevalence in asymptomatic
subjects with normal pulmonary function. Radiology 2003;
227:776–85.
21. Lee ES, Gotway MB, Reddy GP, Golden JA, Keith FM, Webb WR.
Early bronchiolitis obliterans following lung transplantation:
accuracy of expiratory thin-section CT for diagnosis. Radiology
2000;216:472–7.
22. Reichenspurner H, Girgis RE, Robbins RC, Conte JV, Nair RV,
Valentine V, et al. Obliterative bronchiolitis after lung and
heart–lung transplantation. Ann Thorac Surg 1995;60:1845–53.
23. Markopoulo KD, Cool CD, Elliot TL, Lync DA, Newell Jr JD, Hale
VA, et al. Obliterative bronchiolitis: varying presentations and
clinicopathological correlation. Eur Respir J 2002;19:20–30.
